Laboratorios Farmaceuticos Rovi, S.A.
LABFFHealthcare · Stock · monthly payer
Forward Yield
1.63%
Annual Dividend
$1.09
Payout Ratio
26%
5-Yr Growth
—
Ex-Date
Jul 13, 2026
Frequency
Monthly
Summary
As of August 2026, Laboratorios Farmaceuticos Rovi, S.A. (LABFF) yields 1.63% ($1.09 per share annually), with a blended fair-value estimate of $83.76 — +25% upside, so it screens as undervalued. Dividend safety grade: C (59/100).
Is LABFF a good dividend stock?
Yes, with caveatsLaboratorios Farmaceuticos Rovi, S.A. (LABFF) pays a monthly dividend yielding 1.63% ($1.09/yr), with 0 years of growth and a dividend-safety grade of C. It's a solid income payer, but check the caveats below before buying.
Advantages
- Comfortable payout ratio (26%)
Risks
- Cut its dividend in 2025
- Share price is down over the past 5 years
Key Data
- Dividend Yield
- 1.63%
- Payout Ratio
- 26%
- Annual Dividend
- $1.09
- 5-Yr Avg Growth
- —
- Ex-Dividend Date
- Jul 13, 2026
- Years of Growth
- 0
- Frequency
- monthly
- Beta
- 0.23
- Market Cap
- $3.4B
- P/E Ratio
- 16.1
- 5-Yr Total Return
- -5%
- 52-Week Range
- $67.17 – $90.61
- Dividend Safety
- C · 59/100
- Ever Cut?
- Yes (2025)
Frequently Asked Questions
LABFF Price — Last 12 Months
Daily close
Price Return
1 Year
-26%
3 Years
+32%
5 Years
-5%
52-Week Range
$67.17 – $90.61
Price change over each period (excludes dividends). Past performance doesn't guarantee future results.
What is LABFF worth?
Undervaluedlow confidenceOur blended fair-value estimate for Laboratorios Farmaceuticos Rovi, S.A. is $83.76 per share, versus a market price of $67.17. That implies 25% of upside — a margin of safety of about 20%.
Fair Value
$83.76
Current Price
$67.17
Upside
+25%
Margin of Safety
20%
How we get there
Discounted cash flow
Discounts projected free cash flow back to today.
Dividend discount
Discounts the future dividend stream back to today.
Earnings multiple (Graham)
Graham's earnings-multiple formula, anchored to bond yields.
At today's price, the market is pricing in about 15.9% annual free-cash-flow growth. We model 20.0% — below our estimate, leaving room for upside if the business executes.
Assumptions: 7.0% discount rate (CAPM), 20.0% stage-1 growth, 2.5% terminal growth, $4.18 EPS, $1.09 annual dividend. Updated weekly.
Fair-value estimates are model output for educational purposes only — not investment advice or a price target.
LABFF Dividend Safety Score
Borderline
SmarterDividends' proprietary score, backtested against which dividends were actually cut over 15+ years (0.78 AUC). It blends a validated cut-risk model (growth streak, cut history) with current payout, cash-flow and debt. Higher is safer · not investment advice.
Dividend Growth
Total dividends per share by year
Dividend History
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| Jul 13, 2026 | — | $1.1093 | regular |
| Jul 13, 2026 | — | $1.1089 | regular |
| Jul 13, 2026 | — | $1.1080 | regular |
| Jul 13, 2026 | — | $1.1070 | regular |
| Jul 13, 2026 | — | $1.1066 | regular |
| Jul 13, 2026 | — | $1.1059 | regular |
| Jul 13, 2026 | — | $1.1058 | regular |
| Jul 13, 2026 | — | $1.1052 | regular |
| Jul 13, 2026 | — | $1.1044 | regular |
| Jul 13, 2026 | — | $1.1004 | regular |
| Jul 13, 2026 | — | $1.0988 | regular |
| Jul 13, 2026 | — | $1.0983 | regular |
| Jul 13, 2026 | — | $1.0981 | regular |
| Jul 13, 2026 | — | $1.0980 | regular |
Income Calculator
At $1.09 / yr per share
